product 25 in a 71% yield. Only one regioisomer was
observed in this case, which suggests that the reaction is
controlled electronically rather than sterically.12
Scheme 1
.
Proposed Mechanism for the Reaction of Butyric
Acid and Benzyne
Table 1. Reaction of Carboxylic Acids with Arynesa
formed from reaction of phenoxide 7 with a second
equivalent of benzyne, which after dehydration forms the
xanthene 11.
The formation of product 8 encouraged us to pursue this
project, since it provides an expeditious route to o-hy-
droxyaryl ketones, important precursors for the synthesis of
biologically useful flavones and chalcones,9 from readily
available carboxylic acids. Optimization studies revealed that
elevated temperatures (125 °C), dilution of the reaction media
(0.017 M), and the addition of 1.5 equiv of the aryne
precursor 2 and 4 equiv of CsF allow isolation of the desired
product 8 in a 77% yield (Table 1, entry 1). We applied our
optimized conditions to other carboxylic acids (Table 1).
If the benzyne precursor is employed in excess (3 equiv),
it is possible to obtain the dehydrated bis-aryne insertion
product 11 in a 50% yield.10 This method well tolerates
alkene, cycloalkyl, ester, and benzyl functional groups; the
corresponding products 19-22 have been isolated in 58-72%
yields. However, the yields from arenecarboxylic acids are
typically low, with inseparable mixtures of products formed.
One of the most successful reactions is with ꢀ-naphthoic acid
(16), which affords the corresponding o-hydroxyaryl ketone
23 in a 44% yield.
We also envisioned that the in situ formed phenolate anion
7 could potentially undergo a nucleophilic aromatic substitu-
tion reaction. This could provide an interesting route to
xanthones and analogues, which are very important ring
systems in biology and pharmacy.11 Indeed, when o-
halobenzoic acids are allowed to react with the benzyne
precursor and CsF under our optimized conditions, we were
delighted to see formation of the xanthone, with an o-fluoro
substituent being the most efficient among the halogens,
furnishing xanthone (24) in an 80% yield. The 3-methoxy-
benzyne precursor 3-methoxy-2-(trimethylsilyl)phenyl tri-
flate, when reacted with the same acid, provided cyclized
a Reaction conditions: 0.25 mmol of acid, 1.5 equiv of benzyne precursor,
and 4.0 equiv of CsF in 15 mL of THF were heated in a closed vial at 125
°C for 24 h. b Isolated yield. c 3.0 equiv of benzyne precursor, 6.0 equiv of
CsF, and 5 mL of DME were used. d 3-Methoxy-2-(trimethylsilyl)phenyl
triflate was used as the aryne precursor.
We were also delighted to obtain 4-aza-xanthone (26),
albeit in only a 22% yield, starting from 2-chloronicotinic
acid (18), since the majority of the reported reactions
involving benzynes, even under milder reaction conditions,
do not tolerate the nucleophilic nitrogen of a pyridine ring.13
The in situ formed phenolate anion 7 could also potentially
undergo a Michael addition reaction. This would provide a
novel route to biologically important 4-chromanones and
flavones from readily available acrylic and propiolic acids.14
Indeed, when methacrylic acid (27) was allowed to react
under the optimized conditions, 4-chromanone 37 was
formed, but only in a 58% yield. Optimization studies
revealed that addition of the aryne precursor 2 and CsF in
two portions favors formation of the product 37, increasing
(12) For a related observation, see: Dubrovskiy, A. V.; Larock, R. C.
Org. Lett. 2010, 12, 1180.
(9) Kotali, A.; Harris, P. A. Org. Prep. Proc. Int. 1994, 26, 159.
(10) Okuma, K.; Nojima, A.; Matsunaga, N.; Shioji, K. Org. Lett. 2009,
11, 169.
(13) Jeganmohan, M.; Bhuvaneswari, S.; Cheng, C.-H. Chem. Asian J.
2010, 5, 153.
(11) (a) Na, Y. J. Pharm. Pharmacol. 2009, 61, 707. (b) El-Seedi, H. R.;
El-Ghorab, D. M. H.; El-Barbary, M. A.; Zayed, M. F.; Goeransson, U.;
Larsson, S.; Verpoorte, R. Curr. Med. Chem. 2009, 16, 2581. (c) Diderot,
N. T.; Silvere, N.; Etienne, T. AdV. Phytomed. 2006, 2, 273.
(14) (a) Brahmachari, G. Nat. Prod. Commun. 2008, 3, 1337. (b) Horton,
D. A.; Bourne, G. T.; Smythe, M. L. Chem. ReV. 2003, 103, 893. (c) Birt,
D. F.; Hendrich, S.; Wang, W. Pharm. Ther. 2001, 90, 57. (d) Kim, H. P.;
Son, K. H.; Chang, H. W.; Kang, S. S. J. Pharmacol. Sci. 2004, 96, 229.
3118
Org. Lett., Vol. 12, No. 14, 2010